Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

l rate of 51 percent. Subset analyses suggested the greatest benefit occurred in the difficult-to-treat patients with prior myelodysplastic syndrome (MDS) or those that had received prior hypomethylating therapy (HMA). Adverse events were mild, predictable and manageable.

About Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Approximately 14,590 new cases of AML were expected to be diagnosed in the United States in 2013.1 As of January 2008 an estimated 30,993 people were living with (or were in remission from) AML.2 Although AML can occur at any age, adults aged 60 years and older are more likely to develop the disease than younger people. AML is a cancer characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. AML may develop from the progression of other diseases such as myelodysplastic syndrome (MDS), a blood cancer that also affects the bone marrow leading to a decrease in circulating red blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age. The symptoms of AML are caused by replacement of normal bone marrow with leukemic cells, which causes a drop in red blood cells, platelets, and normal white blood cells leading to infections and bleeding. AML progresses rapidly and is typically fatal within weeks or months if left untreated. Although a substantial proportion of younger individuals who develop AML can be cured, AML in the elderly typically responds poorly to standard therapy with few complete remissions.

About CTI
Cell Therapeutics, Inc. (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in Seattle, WA. For additional information and to si
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... and SHANGHAI , Sept. 22, ... a global knowledge leader in healthcare technology, media ... support healthcare innovation in China ... health technologies. Continua and BHG announced this new ... held this week in Washington, DC ...
(Date:9/22/2014)... Md. , Sept. 22, 2014  Neuralstem, Inc. (NYSE ... MD, site investigator at Emory University, presented long-term follow ... human neural stem cells in the treatment of amyotrophic ... The presentation, which occurred at the Annual Symposium on ... Canada , on Friday, and was not open ...
(Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4
... CLEVELAND, Jan. 27, 2012 Neurodevice ... million Series B investment round led ... December 2011, and secured non-dilutive funding ... $1.065 million Innovation Ohio loan and ...
... 27, 2012 Medical Alarm Concepts Holding, Inc. (OTCQB: ... alarm system that allows the user to speak and ... schedule for this week,s media test.   ... Hallmark, Inspirational TV, Fox News Channel, and MSNBC. The ...
Cached Medicine Technology:Neurodevice Firm Checkpoint Surgical Raises $3M 2Medical Alarm Concepts and Harrington Media Announce Final Schedule for MediPendantâ„¢ Nationwide Television Test Launch 2
(Date:9/22/2014)... CA (PRWEB) September 22, 2014 ... treatment for patients who require orthodontic work. Six-Month Smiles ... smile they deserve in a fast and effective way. ... to be extremely daunting. Having to wear metal braces ... certain foods and spend time keeping the braces clean, ...
(Date:9/22/2014)... exercise more and drink more , Study used smartphones ... Findings differ from past research on physical activity and ... finds that on days when people exercise more -- ... too. , This is the only study to use ... physical activity and alcohol use. , "Monday through Wednesday ...
(Date:9/22/2014)... new study pulls back the curtain on one of ... payment and income between physicians who perform operations, procedures ... to perception, the research indicates, the physician payment system ... procedure-performing doctors. , The new findings counter the widely ... minute explains why doctors who perform procedures often earn ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... children aged 6 months and older be vaccinated for the ... their influenza vaccine recommendations to advise that the youngest kids ... The AAP also wants parents of children aged 2 to ... instead of the flu shot if it,s readily available. ...
(Date:9/22/2014)... New York Malaysia today became a founding partner ... dollar initiative dedicated to promoting young talent in science, ... Led by the New York Academy of Sciences (NYAS), ... at UN Headquarters Monday Sept. 22. , With the ... more than 100 countries by 2020, the initiative will ...
Breaking Medicine News(10 mins):Health News:Starbrite Dental Introduces Six-Month Smiles 2Health News:We drink more alcohol on gym days 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3
... strongly propose that diabetes newly diagnosed in people above ... pancreatic cancer.// Older patients whose diabetes began late in ... with pancreatic cancer within three years following onset of ... people in their 70s when diabetes first appeared. ...
... men are putting their lives at risk because they fail ... embarrassed to consult their general practitioner if they feel a ... case study involving a young man who was involved ... days later he died of a blood clot in the ...
... The functioning of stem cells has an outstanding nature. Initially, ... cells, promising repair of damaged lung tissue. The potential of ... more specialised cells - is now well established.// Researchers at ... first creation of lung cells from stem cells in mice. ...
... at the Hopkins University, working with yeast have ... the replication of HIV inside cells, a finding that ... for the virus that causes AIDS.//,A team of researchers ... virus depends on an enzyme called reverse transcriptase to ...
... new study taking cholesterol-lowering drugs called 'statins' could elevate ... research has shown the benefits of statins, drugs that ... that the drugs might// increase their risk of peripheral ... in the hands and feet. ,The research team ...
... hearing loss are going down well with those who use ... aged over 60 in the United States. Traditionally there was ... acoustic hearing aid. // ,Now, however, there's another choice ... the surrounding bones. Researchers in the US have surveyed 100 ...
Cached Medicine News:Health News:Pancreatic Cancer may be linked to Diabetes 2Health News:Patients with testicular cancer dying through unfamiliarity 2Health News:Elevating Manganese Levels hold back HIV 2
... Human Insulin-like growth factor binding protein-2 ... (further IGFBPs have been proposed) which specifically ... and IGF-II. The binding affinity of IGFBP-2 ... higher than for IGF-I [1], suggesting a ...
... Insulin-like growth factor binding protein-2 (IGFBP-2) is ... have been proposed) which specifically bind and ... The binding affinity of IGFBP-2 for IGF-II ... for IGF-I [1], suggesting a role in ...
... Androstenedione, produced in the adrenal gland and ... testosterone and estrone, both of which may ... relatively weak androgenic activity, estimated at ~(less ... [1]. However, serum androstenedione levels often exceed ...
... proteins that suppress the secretion of FSH ... consists of two distinct chains, or subunits ... consists of the alpha-subunit and betaA-subunit. Inhibin ... Only the dimeric forms of the molecule, ...
Medicine Products: